HIV/AIDS Flashcards
Population at highest risk of HIV
- men who have make sexual partners
- people from sub Saharan Africa
- children of people living with HIV
-people who inject drugs - people who have transactional sex
HIV Testing
- tests antigen and HIV antibody
- window period 45 days
-can do rapid tests or finger prick tests as well
Primary HIV infection
- six weeks after patient acquire HIV, will get Primary HIV or Seroconverison
- body’s immune system is providing a big immune response to the virus
-symptoms: fever, sore throat, feeling fatigue, rash, swollen lymph glands - can be mistaken for glandular fever, secondary syphilis
Blood tests for HIV
HIV viral load
- marker of how much HIV is present in the blood. Aim to maintain an ‘undetectable viral load’ <200-20 copies/ml
CD4
- type of white blood cell, calculated from total lymphocyte count
- stops HIV from replicating and destroying CD4
HIV Treatment
- reduces morbidity and mortality
-reduces risk of onward transmission
-aim of treatment is VL (viral lode) suppression and CD4 recovery
HAART- Highly Active AntiRetroviral Treatment
- usually triple therapy: 2 nucleoside reverse transcriptase inhibitors and 1 drug from another class
-guided by patients choice/ drug resistance
Challenges with Antiretroviral Therapy
-good adherence essential (need to take drugs everyday)
- psychological impact
-short term side effects
-long term toxicities
-drug-drug interactions (topical/inhaled drugs)
HIV prevention
-condoms
- treatment as prevention (TasP)
- pre exposure prophylaxis (Prep)
- post exposure prophylaxis (pep)
- prevention of mother to child transmission (PMTCT)
-harm reduction measures eg. Needle exchange
PEP vs PrEP
PEP
- post exposure prophylaxis
Based on exposure type and risk of contact
PrEP
- pre exposure prophylaxis
- for people at higher risk of HIV through sexual transmission
- long term effect on kidneys and bones
Prevention of mother to child HIV transmission
- ART for mother during pregnancy minimises risk at delivery
- PEP for baby
- avoid breast feeding
- universal antenatal HIV screening
Social dimension of HIV/AIDS
- high prevelance in many counties with low GDP
Provision of ART and clinical monitoring - often affects people from marginalised populations
At risk of further marginalisation - high rates of psychological ill health in people living with HIV
-stigma and isolation
Social dimension of HIV/AIDS
- high prevelance in many counties with low GDP
Provision of ART and clinical monitoring - often affects people from marginalised populations
At risk of further marginalisation - high rates of psychological ill health in people living with HIV
-stigma and isolation